首页> 外国专利> QUANTITATIVE RT-PCR TO AC133 TO DIAGNOSE CANCER AND MONITOR ANGIOGENIC ACTIVITY IN A CELL SAMPLE

QUANTITATIVE RT-PCR TO AC133 TO DIAGNOSE CANCER AND MONITOR ANGIOGENIC ACTIVITY IN A CELL SAMPLE

机译：AC133的定量RT-PCR诊断细胞样品中的癌症和监测血管生成活性

页面导航

摘要
著录项
相似文献

摘要

The present invention involves the use of quantitative RT-PCR to identify AC133 as a marker. AC133 is prevalent on endothelial progenitor cells (EPCs), which are important cells in angiogenesis. Therefore, the invention is applied to ascertain the quantity of EPCs in a subject, and to diagnose and monitor angiogenesis, for example, in injured tissues and in cancer development and progression.

机译：本发明涉及使用定量RT-PCR来鉴定AC133作为标记。 AC133在内皮祖细胞（EPC）上很普遍，内皮祖细胞是血管生成中的重要细胞。因此，本发明被用于确定受试者中EPC的量，并且例如在受伤的组织中以及在癌症的发展和进展中诊断和监测血管生成。

著录项

公开/公告号KR20050034749A

专利类型
公开/公告日2005-04-14

原文格式PDF
申请/专利权人 THE BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM;
展开▼

申请/专利号KR20057003352
发明设计人 WU XIFENG;LIN EDWARD H.;XIE KEPING;
展开▼

申请日2005-02-25
分类号C12Q1/68;G01N33/574;C12P19/34;
国家 KR
入库时间 2022-08-21 22:05:32

相似文献

专利
外文文献
中文文献